The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Wednesday: ** U.S. drugmaker Pfizer, which failed last month in a $118 billion bid to purchase AstraZeneca, said it had signed a deal with French biotech Cellectis to develop immunotherapy drugs in cancer.** Australian iron ore developer Aquila Resources Ltd told shareholders to accept a takeover offer led by Chinese steel giant Baosteel Resources valuing the company at $1.3 billion, in a surprise move after rejecting a higher rival bid.
Aquila Resources Inc. (Aquila) is a natural resource company engaged in the acquisition, exploration and development of the Back Forty Project and other base and precious metal projects in the United States. Shares of AQA remained unchanged at $0.10. In the past year, the shares have traded as low as $0.08 and as high as $0.17. On average, 36802 shares of AQA.TO exchange hands on a given day and today's volume is recorded at 5000.
Source
